STERIS plc (STE)
NYSE: STE · IEX Real-Time Price · USD
224.29
-1.16 (-0.51%)
At close: Jul 19, 2024, 4:00 PM
224.33
+0.04 (0.02%)
After-hours: Jul 20, 2024, 12:57 PM EDT

STERIS Revenue

In the fiscal year ending March 31, 2024, STERIS had annual revenue of $5.14B with 13.28% growth. Revenue in the quarter ending March 31, 2024 was $1.12B with 15.87% year-over-year growth.

Revenue (ttm)
$5.14B
Revenue Growth
+13.28%
P/S Ratio
4.31
Revenue / Employee
$282,672
Employees
18,179
Market Cap
22.17B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 20245.14B602.44M13.28%
Mar 31, 20234.54B312.86M7.41%
Mar 31, 20224.22B1.12B35.91%
Mar 31, 20213.11B76.62M2.53%
Mar 31, 20203.03B248.73M8.94%
Mar 31, 20192.78B162.17M6.19%
Mar 31, 20182.62B7.24M0.28%
Mar 31, 20172.61B373.99M16.71%
Mar 31, 20162.24B388.50M21.00%
Mar 31, 20151.85B228.01M14.06%
Mar 30, 20141.62B1.08B199.38%
Mar 31, 2013541.87M73.94M15.80%
Apr 1, 2012467.93M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cardinal Health 220.57B
Koninklijke Philips 20.19B
Teva Pharmaceutical 16.00B
ICON PLC 8.23B
Zimmer Biomet Holdings 7.45B
Illumina 4.49B
Hologic 3.96B
Align Technology 3.92B
Revenue Rankings